鞘膜积液的硬化疗法。

Sclerotherapy for hydroceles.

作者信息

Rencken R K, Bornman M S, Reif S, Olivier I

机构信息

Department of Urology, Medical University of Southern Africa, Pretoria.

出版信息

J Urol. 1990 May;143(5):940-3.

PMID:2329610

Abstract

Sclerotherapy with 3% sodium tetradecyl sulfate and 3.5% rolitetracycline on an outpatient basis was applied to 55 hydroceles. The over-all cure rate was 96% with an average followup of 13 months. Of the patients 64% were cured after only 1 sclerosant instillation. A post-sclerotherapy operation was necessary in 4% of the patients. Pain of a significant degree occurred after sclerotherapy in only 29% of the patients. Sclerotherapy appears to be an effective, economical and safe form of outpatient therapy for hydroceles.

摘要

对55例鞘膜积液患者进行门诊3%十四烷基硫酸钠和3.5% rolitetracycline硬化治疗。总体治愈率为96%，平均随访13个月。64%的患者仅注射1次硬化剂后即治愈。4%的患者需要进行硬化治疗后手术。仅29%的患者在硬化治疗后出现明显疼痛。硬化治疗似乎是一种有效、经济且安全的鞘膜积液门诊治疗方式。